Join
Live feed
·
INSIDERFilingvia Quantisnow
Rezolute Inc. logo

SEC Form 4: Genexine Inc. converted options into 56,818,175 units of Common Stock and bought $10,000,000 worth of Common Stock (34,482,758 units at $0.29)

ByQuantisnow·Wall Street's wire, on your screen.
RZLT· Rezolute Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RZLT (Rezolute Inc.) and more on Quantisnow.